SCHEMBL752899

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL756456	0.89	LIPG (0.52)	LIPG
	SCHEMBL756448	0.88	LIPG (0.42)	LIPGALDH1A1POLBLMNATSHR
	SCHEMBL754217	0.86	LIPG (0.40)	LIPGALDH1A1POLBLMNATSHR
	SCHEMBL14259598	0.86	LIPG (0.41)	LIPGLIPC
	SCHEMBL2486832	0.86	ALDH1A1 (0.41)	LIPGALDH1A1POLBLMNATSHR
	SCHEMBL14259599	0.86	LIPG (0.43)	LIPGALDH1A1POLBLIPC
	SCHEMBL754447	0.85	LIPG (0.41)	LIPGALDH1A1POLBLMNATSHR
	SCHEMBL752004	0.85	ALDH1A1 (0.40)	LIPGALDH1A1POLBLMNATSHR
	SCHEMBL2489852	0.85	LIPG (0.44)	LIPGALDH1A1POLB
	SCHEMBL752850	0.84	LIPG (0.47)	LIPGLIPC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.